Mirae Asset Global ETFs Holdings
CRBP icon

Mirae Asset Global ETFs Holdings’s Corbus Pharmaceuticals CRBP Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Sell
151,640
-8,822
-5% -$83.5K ﹤0.01% 1441
2026
Q1 		$1.51M Sell
160,462
-21,600
-12% -$182K ﹤0.01% 1316
2025
Q4 		$1.48M Buy
182,062
+96,236
+112% +$1.19M ﹤0.01% 1308
2025
Q3 		$1.09M Sell
85,826
-33,230
-28% -$316K ﹤0.01% 1440
2025
Q2 		$821K Sell
119,056
-9,987
-8% -$72.5K ﹤0.01% 1546
2025
Q1 		$685K Sell
129,043
-33,919
-21% -$299K ﹤0.01% 1689
2024
Q4 		$1.92M Sell
162,962
-9,668
-6% -$162K ﹤0.01% 1158
2024
Q3 		$3.56M Buy
172,630
+142,506
+473% +$7.29M 0.01% 874
2024
Q2 		$1.36M Buy
+30,124
New +$1.27M ﹤0.01% 1282

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CRBP Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Corbus Pharmaceuticals (CRBP) stake by 5.5% in Q2 2026, selling an estimated $83.5K and leaving 151,640 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1441.

Mirae Asset Global ETFs Holdings first reported a position in CRBP in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.56M in Q3 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 151,640 shares of Corbus Pharmaceuticals worth $1.42M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 8,822 Corbus Pharmaceuticals shares in Q2 2026, an estimated $83.5K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1441 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Corbus Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Corbus Pharmaceuticals position peaked at $3.56M in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.